Single-step purification and refolding of recombinant mouse and human myelin oligodendrocyte glycoprotein and induction of EAE in mice

Protein Expression and Purification

Volumn 34, Issue 2, 2004, Pages 249-256

  Liñares, David ^a,b   Echevarria, Iñigo ^c   Mañá, Paula ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b LA TROBE UNIVERSITY   (Australia)

^c DUPONT COMPANY   (United States)

Author keywords

129 Sv; EAE; Mouse ED MOG; On column refolding; Purification

Indexed keywords

ANIMALIA; ESCHERICHIA COLI;

EID: 12144289421     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2003.11.016     Document Type: Article

References (35)

1. P. Amiguet, M.V. Gardinier, J.P. Zanetta, J.M. Matthieu, Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein, J. Neurochem. 58 (1992) 1676-1682.
2. S. Abo, C.C. Bernard, M. Webb, T.G. Johns, A. Alafaci, L.D. Ward, R.J. Simpson, N. Kerlero de Rosbo, Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies, Biochem. Mol. Biol. Int. 30 (1993) 945-958.
3. P. Daubas, D. Pham-Dinh, A. Dautigny, Structure and polymorphism of the mouse myelin/oligodendrocyte glycoprotein gene, Genomics 23 (1994) 36-41.
4. M.V. Gardinier, P. Amiguet, C. Linington, J.M. Matthieu, Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily, J. Neurosci. Res. 33 (1992) 177-187.
5. D. Pham-Dinh, B. Allinquant, M. Ruberg, B. Della Gaspera, J.L. Nussbaum, A. Dautigny, Characterization and expression of the cDNA coding for the human myelin/oligodendrocyte glycoprotein, J. Neurochem. 63 (1994) 2353-2356.
6. M.P. Roth, L. Malfroy, C. Offer, J. Sevin, G. Enault, N. Borot, P. Pontarotti, H. Coppin, The human myelin oligodendrocyte glycoprotein (MOG) gene: complete nucleotide sequence and structural characterization, Genomics 28 (1995) 241-250.
7. D. Pham-Dinh, E.P. Jones, G. Pitiot, B. Della Gaspera, P. Daubas, J. Mallet, D. Le Paslier, K. Fischer Lindahl, A. Dautigny, Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region, Immunogenetics 42 (1995) 386-391.
8. D. Lambracht, C. Prokop, H.J. Hedrich, K. Fischer Lindahl, K. Wonigeit, Mapping of H2-M homolog and MOG genes in the rat MHC, Immunogenetics 42 (1995) 418-421.
9. J.F. Kroepfl, L.R. Viise, A.J. Charron, C. Linington, M.V. Gardinier, Investigation of myelin/oligodendrocyte glycoprotein membrane topology, J. Neurochem. 67 (1996) 2219-2222.
10. B. della Gaspera, D. Pham-Dinh, G. Roussel, J.L. Nussbaum, A. Dautigny, Membrane topology of the myelin/oligodendrocyte glycoprotein, Eur. J. Biochem. 258 (1998) 478-484.
11. D. Pham-Dinh, M.G. Mattei, J.L. Nussbaum, G. Roussel, P. Pontarotti, N. Roeckel, I.H. Mather, K. Artzt, K.F. Lindahl, A. Dautigny, Myelin/ oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex, Proc. Natl. Acad. Sci. USA 90 (1993) 7990-7994.
12. R.B. Lindert, C.G. Haase, U. Brehm, C. Linington, H. Wekerle, R. Hohlfeld, Multiple sclerosis: B-and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein, Brain 122 (Pt 11) (1999) 2089-2100.
13. C.G. Haase, J. Guggenmos, U. Brehm, M. Andersson, T. Olsson, M. Reindl, J.M. Schneidewind, U.K. Zettl, F. Heidenreich, T. Berger, H. Wekerle, R. Hohlfeld, C. Linington, The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls, J. Neuroimmunol. 114 (2001) 220-225.
14. H.C. von Budingen, S.L. Hauser, A. Fuhrmann, C.B. Nabavi, J.I. Lee, C.P. Genain, Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination, Proc. Natl. Acad. Sci. USA 99 (2002) 8207-8212.
15. H.C. von Budingen, N. Tanuma, P. Villoslada, J.C. Ouallet, S.L. Hauser, C.P. Genain, Immune responses against the myelin/ oligodendrocyte glycoprotein in experimental autoimmune demyelination, J. Clin. Immunol. 21 (2001) 155-170.
16. A. Iglesias, J. Bauer, T. Litzenburger, A. Schubart, C. Linington, T-and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis, Glia 36 (2001) 220-234.
17. J. Bettadapura, K.K. Menon, S. Moritz, J. Liu, C.C. Bernard, Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein, J. Neurochem. 70 (1998) 1593-1599.
18. S. Amor, N. Groome, C. Linington, M.M. Morris, K. Dornmair, M.V. Gardinier, J.M. Matthieu, D. Baker, Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/ H mice, J. Immunol. 153 (1994) 4349-4356.
19. J. Liu, M.W. Marino, G. Wong, D. Grail, A. Dunn, J. Bettadapura, A.J. Slavin, L. Old, C.C. Bernard, TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination, Nat. Med. 4 (1998) 78-83.
20. K.L. Franken, H.S. Hiemstra, K.E. van Meijgaarden, Y. Subronto, J. den Hartigh, T.H. Ottenhoff, J.W. Drijfhout, Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent, Protein Expr. Purif. 18 (2000) 95-99.
21. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970) 680-685.
22. C. Linnington, M. Webb, P.L. Woodhams, A novel myelin-associated glycoprotein denned by a mouse monoclonal antibody, J. Neuroimmunol. 6 (1984) 387-396.
23. T. Ohashi, M. Yukitake, A. Slavin, J. Krieger, D.A. Hafler, In vitro evidence that immunoaffinity-purified MOG contains immunogenic quantities of contaminating mouse IgG; techniques for producing Ig-free MOG, J. Neuroimmunol. 118 (2001) 194-202.
24. F. Baneyx, Recombinant protein expression in Escherichia coli, Curr. Opin. Biotechnol. 10 (1999) 411-421.
25. S. Misawa, I. Kumagai, Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies, Biopolymers 51 (1999) 297-307.
26. E.D.B. Clark, Refolding of recombinant proteins, Curr. Opin. Biotechnol. 9 (1998) 157-163.
27. L.R. Banghart, C.W. Chamberlain, J. Velarde, I.V. Korobko, S.L. Ogg, L.J. Jack, V.N. Vakharia, I.H. Mather, Butyrophilin is expressed in mammary epithelial cells from a single-sized messenger RNA as a type I membrane glycoprotein, J. Biol. Chem. 273 (1998) 4171-4179.
28. C. Breithaupt, A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, U. Jacob, Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein, Proc. Natl. Acad. Sci. USA 100 (2003) 9446-9451.
29. H. Lilie, E. Schwarz, R. Rudolph, Advances in refolding of proteins produced in E. coli, Curr. Opin. Biotechnol. 9 (1998) 497-501.
30. A. Holzinger, K.S. Phillips, T.E. Weaver, Single-step purification/ solubilization of recombinant proteins: application to surfactant protein B, Biotechniques 20 (1996) 804-806, 808.
31. J.A. Lyons, M.J. Ramsbottom, A.H. Cross, Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein, Eur. J. Immunol. 32 (2002) 1905-1913.
32. A.R. Oliver, G.M. Lyon, N.H. Ruddle, Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice, J. Immunol. 171 (2003) 462-468.
33. D.O. Willenborg, S.A. Fordham, M.A. Staykova, I.A. Ramshaw, W.B. Cowden, IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide, J. Immunol. 163 (1999) 5278-5286.
34. C. Espejo, J. Carrasco, J. Hidalgo, M. Penkowa, A. Garcia, I. Saez-Torres, E.M. Martinez-Caceres, Differential expression of metallothioneins in the CNS of mice with experimental autoimmune encephalomyelitis, Neuroscience 105 (2001) 1055-1065.
35. S. Albouz-Abo, J.C. Wilson, C.C. Bernard, M. von Itzstein, A conformational study of the human and rat encephalitogenic myelin oligodendrocyte glycoprotein peptides 35-55, Eur. J. Biochem. 246 (1997) 59-70.